Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognised form of heart muscle disease, which affects other body organs and can be fatal. With earlier diagnosis and genetic testing, holistic treatment can begin and help identify family members who may also be at risk of this condition. With advancements in therapeutic options, patients can recover better.
Learn more about ATTR-CM in our public forum! To register for this free webinar, please visit here.
Read more about ATTR-CM here.
